Discovery of Agonists of Cannabinoid Receptor 1 with Restricted Central Nervous System Penetration Aimed for Treatment of Gastroesophageal Reflux Disease
Alleyn T. Plowright(AstraZeneca (Sweden)), Johan Ulander(AstraZeneca (Australia)), Johan Broddefalk(AstraZeneca (Sweden)), Kosrat Amin(Albany Molecular Research (United States)), Mirosław J. Tomaszewski(AstraZeneca (Poland)), Madeleine Antonsson, Hua Yang(Affiliated Hospital of Guizhou Medical University), Karolina Nilsson, Jörgen Jensen, Zhongyong Wei(AstraZeneca (Poland)), Stéphane St-Onge(AstraZeneca (Poland)), Shujuan Jin(Chinese PLA General Hospital), Christopher Walpole(AstraZeneca (Poland)), Anders Lehmann(AstraZeneca (United Kingdom)), Maxime Tremblay(Université Laval)
Cited by 19
Related Papers
Ischemia-Induced Shift of Inhibitory and Excitatory Amino Acids from Intra- to Extracellular Compartments
|Journal of Cerebral Blood Flow & Metabolism|1985|660
Oxadiazoles in Medicinal Chemistry
|Journal of Medicinal Chemistry|2011|593
Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest
|Proceedings of the National Academy of Sciences|2017|482